SCHEMBL7708631

SCHEMBL7708631

COC(=O)Cc1cc(Br)ccc1Sc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
NPSR1 Q6W5P4 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44
MMP2 P08253 2/20 0.43
MMP9 P14780 2/20 0.43
MMP12 P39900 2/20 0.43
MMP14 P50281 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
KMT2A Q03164 1/20 0.42
MAPT P10636 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2562284 0.84 CYP2C9 (0.54) L3MBTL1CYP2C9CYP2C19NPSR1CYP1A2
SCHEMBL7030014 0.81 SMN1; SMN2 (0.41) L3MBTL1MMP2MMP9MMP12MMP14
SCHEMBL9630994 0.80 HTT (0.42) L3MBTL1CYP2C9CYP2C19CYP1A2CYP2D6
SCHEMBL9630038 0.80 AGBL2 (0.46) L3MBTL1CYP1A2MMP2MMP9MMP12
SCHEMBL7037491 0.80 AGBL2 (0.46) L3MBTL1CYP2C9CYP2C19CYP2D6MMP2
SCHEMBL9631099 0.78 L3MBTL1 (0.39) L3MBTL1CYP2C9CYP2C19CYP2D6MMP2
SCHEMBL28370615 0.78 AGBL2 (0.45) L3MBTL1CYP2C9CYP2C19NPSR1CYP1A2
SCHEMBL11707313 0.78 SLC6A4 (0.61) L3MBTL1CYP2C9CYP2C19NPSR1CYP1A2
SCHEMBL11577641 0.76 MAPT (0.50) L3MBTL1CYP2C19CYP1A2CYP3A4MMP2
SCHEMBL11706477 0.76 ALDH1A1 (0.52) L3MBTL1CYP2C9CYP2C19NPSR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011130741-A1 COMPOUNDS FOR TREATING NEURODEGENERATIVE DISEASES ARRAY BIOPHARMA INC. (US) 2011-10-20 WO disclosed